全文获取类型
收费全文 | 3225篇 |
免费 | 238篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 134篇 |
妇产科学 | 95篇 |
基础医学 | 517篇 |
口腔科学 | 36篇 |
临床医学 | 274篇 |
内科学 | 770篇 |
皮肤病学 | 80篇 |
神经病学 | 392篇 |
特种医学 | 85篇 |
外科学 | 314篇 |
综合类 | 13篇 |
一般理论 | 1篇 |
预防医学 | 210篇 |
眼科学 | 23篇 |
药学 | 223篇 |
中国医学 | 5篇 |
肿瘤学 | 286篇 |
出版年
2024年 | 4篇 |
2023年 | 40篇 |
2022年 | 88篇 |
2021年 | 144篇 |
2020年 | 100篇 |
2019年 | 123篇 |
2018年 | 114篇 |
2017年 | 97篇 |
2016年 | 106篇 |
2015年 | 123篇 |
2014年 | 167篇 |
2013年 | 189篇 |
2012年 | 301篇 |
2011年 | 294篇 |
2010年 | 149篇 |
2009年 | 137篇 |
2008年 | 250篇 |
2007年 | 207篇 |
2006年 | 170篇 |
2005年 | 180篇 |
2004年 | 136篇 |
2003年 | 118篇 |
2002年 | 79篇 |
2001年 | 15篇 |
2000年 | 12篇 |
1999年 | 13篇 |
1998年 | 16篇 |
1997年 | 14篇 |
1996年 | 19篇 |
1995年 | 5篇 |
1994年 | 5篇 |
1993年 | 9篇 |
1992年 | 6篇 |
1991年 | 7篇 |
1990年 | 3篇 |
1988年 | 5篇 |
1987年 | 1篇 |
1986年 | 7篇 |
1985年 | 4篇 |
1984年 | 6篇 |
1983年 | 1篇 |
1980年 | 3篇 |
1979年 | 1篇 |
1975年 | 1篇 |
1974年 | 2篇 |
1972年 | 1篇 |
1971年 | 2篇 |
1970年 | 2篇 |
1967年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有3478条查询结果,搜索用时 46 毫秒
61.
B. Fuentes S. Amaro M. Alonso de Leciñana J.F. Arenillas O. Ayo-Martín M. Castellanos M. Freijo A. García-Pastor M. Gomis M. Gómez Choco E. López-Cancio P. Martínez Sánchez A. Morales E.J. Palacio-Portilla M. Rodríguez-Yáñez J. Roquer T. Segura J. Serena J. Vivancos-Mora 《Neurología (Barcelona, Spain)》2021,36(4):305-323
ObjectiveTo update the Spanish Society of Neurology's guidelines for stroke prevention in patients with type 2 diabetes or prediabetes, analysing the available evidence on the effect of metabolic control and the potential benefit of antidiabetic drugs with known vascular benefits in addition to conventional antidiabetic treatments in stroke prevention.DevelopmentPICO-type questions (Patient, Intervention, Comparison, Outcome) were developed to identify practical issues in the management of stroke patients and to establish specific recommendations for each of them. Subsequently, we conducted systematic reviews of the PubMed database and selected those randomised clinical trials evaluating stroke as an independent variable (primary or secondary). Finally, for each of the PICO questions we developed a meta-analysis to support the final recommendations.ConclusionsWhile there is no evidence that metabolic control reduces the risk of stroke, some families of antidiabetic drugs with vascular benefits have been shown to reduce these effects when added to conventional treatments, both in the field of primary prevention in patients presenting type 2 diabetes and high vascular risk or established atherosclerosis (GLP-1 agonists) and in secondary stroke prevention in patients with type 2 diabetes or prediabetes (pioglitazone). 相似文献
62.
Paola Stefanelli Antonino Bella Giorgio Fedele Serena Pancheri Pasqualina Leone Paola Vacca Arianna Neri Anna Carannante Cecilia Fazio Eleonora Benedetti Stefano Fiore Concetta Fabiani Maurizio Simmaco Iolanda Santino Maria Grazia Zuccali Giancarlo Bizzarri Rosa Magnoni Pier Paolo Benetollo Antonio Ferro 《Clinical microbiology and infection》2021,27(4):633.e1-633.e7
ObjectivesA seroprevalence study of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was conducted in a high-incidence area located in northeastern Italy.MethodsAll citizens above 10 years of age resident in five municipalities of the Autonomous Province of Trento, with the highest incidence of coronavirus disease 2019 (COVID-19) cases, were invited to participate in the study. Among 6098 participants, 6075 sera and a standardized questionnaire administered face-to-face were collected between 5 May and 15 May 2020 and examined. Symptomatic individuals and their family contacts were tested by RT-PCR. Anti-SARS-CoV-2 antibodies were detected using an Abbott SARS-CoV-2 IgG assay, which was performed on the Abbott Architect i2000SR automated analyser. Seroprevalence was calculated as the proportion of positive results among the total number tested. A multivariable logistic regression model was performed to assess the relationship between seropositive versus seronegative individuals for a set of explanatory variables.ResultsA total of 1402 participants were positive for IgG antibodies against SARS-CoV-2, with a prevalence of 23.1% (1402/6075). The highest prevalence was found in the age class 40–49 years. Overall, 34.4% (2096/6098) of the participants reported at least one symptom. The ratio between reported cases identified by molecular test and those with seropositive results was 1:3, with a maximum ratio of about 1:7 in the age group <20 years and a minimum around 1:1 in those >70 years old. The infection fatality rate was 2.5% (35/1402). Among the symptoms, anosmia and ageusia were strongly associated with seropositivity.ConclusionsThe estimated seroprevalence of 23% was three-fold higher than the number of cases reported in the COVID-19 Integrated Surveillance data in the study area. This may be explained in part by a relatively high number of individuals presenting mild or no illness, especially those of younger age, and people who did not seek medical care or testing, but who may contribute to virus transmission in the community. 相似文献
63.
Timothy D. Smith Brent A. Craven Serena M. Engel Blaire Van Valkenburgh Valerie B. DeLeon 《Anatomical record (Hoboken, N.J. : 2007)》2021,304(1):127-138
Nasal turbinals, delicate and complex bones of the nasal cavity that support respiratory or olfactory mucosa (OM), are now easily studied using high resolution micro-computed tomography (μ-CT). Standard μ-CT currently lacks the capacity to identify OM or other mucosa types without additional radio-opaque staining techniques. However, even unstained mucosa is more radio-opaque than air, and thus mucosal thickness can be discerned. Here, we assess mucosal thickness of the nasal fossa using the cranium of a cadaveric adult dog that was μ-CT scanned with an isotropic resolution of 30 μm, and subsequently histologically sectioned and stained. After co-alignment of μ-CT slice planes to that of histology, mucosal thickness was estimated at four locations. Results based on either μ-CT or histology indicate olfactory mucosa is thicker on average compared with non-olfactory mucosa (non-OM). In addition, olfactory mucosa has a lesser degree of variability than the non-OM. Variability in the latter appears to relate mostly to the varying degree of vascularity of the lamina propria. Because of this, in structures with both specialized vascular respiratory mucosa and OM, such as the first ethmoturbinal (ET I), the range of thickness of OM and non-OM may overlap. Future work should assess the utility of diffusible iodine-based contrast enhanced CT techniques, which can differentiate epithelium from the lamina propria, to enhance our ability to differentiate mucosa types on more rostral ethmoturbinals. This is especially critical for structures such as ET I, which have mixed functional roles in many mammals. 相似文献
64.
65.
66.
Elizabeth Yarad Anne O'Connor Jason Meyer Matthew Tinker Serena Knowles Yang Li Naomi E. Hammond 《Australian critical care》2021,34(1):60-66
BackgroundPressure injuries (PIs) are a patient safety issue that impact patient outcomes. Intensive care unit (ICU) patients are at high risk of PIs.ObjectivesTo report the prevalence and classification of documented PIs in adult ICU patients, the use of pressure injury risk assessment tools, and support surface management as a part of the prevention of PIs.MethodsThis was a prospective, single-day, multicentre, cross-sectional study of patients aged ≥ 16 years admitted to adult ICUs in Australia and New Zealand (ANZ), August 2016 as part of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG) Point Prevalence Program.FindingsData were collected on 671 patients (58% male) in 47 ICUs. The mean [standard deviation] age and weight were 60.2 years [17.2 years] and 82.1 kg [29.7 kg], respectively, with a severity of illness score (Acute Physiology and Chronic Health Evaluation [APACHE] II) of 18.2 [8.4]. PIs were reported in 10% (70/671) of patients. Patients with a PI had a mean APACHE II score of 22.5 [standard deviation; 7.7], and 57.1% (40/70) met the criteria for sepsis on the study day. There were 107 PIs documented on the study day (N = 107) in the 70 patients with nearly half of PIs present on ICU admission (46.7%; 50/107). The sacrum was the most common location for PIs (28.9%; 31/107) and then the heels (15.9%; 17/107). All units routinely use a risk of PI assessment tool and were cared for on an active or reactive support surface. Patients with a PI were more often moved to an active support surface.ConclusionsThe prevalence rate was reported at 10% for PIs for adult intensive care patients on the study day. More than half of the patients with a PI had signs of sepsis on the study day and a higher severity of illness, and more were cared for on active support surfaces. Most PIs were located at the sacrum and then the heels. All clinical sites routinely used a PI risk assessment tool. 相似文献
67.
68.
69.
Prognostic role of nuclear factor/IB and bone remodeling proteins in metastatic giant cell tumor of bone: A retrospective study
下载免费PDF全文
![点击此处可从《Journal of orthopaedic research》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Irene Quattrini Serena Pollino Laura Pazzaglia Amalia Conti Chiara Novello Cristina Ferrari Elettra Pignotti Piero Picci Maria Serena Benassi 《Journal of orthopaedic research》2015,33(8):1205-1211
Giant cell tumor of bone (GCTb) represents 5% of bone tumors, and although considered benign, 5% metastasize to the lung. The expression of proteins directly or indirectly associated with osteolysis and tumor growth was studied on 163 samples of GCTb. Of these, 33 patients developed lung metastasis during follow‐up. The impact of tumor–host interaction on clinical aspects was evaluated with the aim of finding specific markers for new biological therapies, thus improving clinical management of GCTb. Protein expression was evaluated by immunohistochemical analysis on Tissue Microarray. The majority of GCTb samples from patients with metastatic disease were strongly positive to RANKL and its receptor RANK as well as to CAII and MMP‐2 and to pro‐survival proteins NFIB and c‐Fos. Kaplan–Meier analysis indicated a significant difference in metastasis free survival curves based on protein staining. Interestingly, the statistical correlation established a strong association between all variables studied with a higher τ coefficient for RANK/RANKL, RANK/NFIB, and RANKL/NFIB pairs. At multivariate analysis co‐overexpression of NFIB, RANK and RANKL significantly increased the risk of metastasis with an odds ratio of 13.59 (95%CI 4.12–44.82; p < 0.0005). In conclusion, the interconnection between matrix remodeling and tumor cell activity may identify tumor–host endpoints for new biological treatments. © 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 33:1205–1211, 2015. 相似文献
70.